Grundinformationen
- Standard-SMILES
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)O- InChIKey
RBHBOUYXUXWCNJ-WDZFZDKYSA-N- Summenformel
- C16H13FN2O3
- Durchschnittliche Molmasse
- 300,28 g/mol
Namen und Bezeichner
- Bevorzugter Name
- Sunitinib acid
- IUPAC
- 5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
- Englischer Name
- 5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
- Summenformel
- C16H13FN2O3
- Molmasse
- 300.28
Namen und Synonyme
356068-93-4Sunitinib acid3TA57TDQ6K1H-Pyrrole-3-carboxylic acid, 5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-5-((Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid(3Z)-3-((3,5-Dimethyl-4-carboxy-1H-pyrrol-2-yl)methylidene)-5-fluoro-1,3-dihydro-2H-indol-2-oneRefChem:203174(3Z)-3-[(3,5-dimethyl-4-carboxy-1H-pyrrol-2-yl)methylidene]-5-fluoro-1,3-dihydro-2H-indol-2-one5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid452105-33-8(Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
Weitere Namen anzeigen
Sunitinib Intermediate 7Malate Sunitinib Impurities A(Z)-Sunitinib carboxylic acid5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl...Cefatrizine Propylene Glycol Impurity 1(Cefatrizine Propylene Glycol EP Impurity A)(Z)-5-[(5-Fluoro-2-oxoindolin-3-ylidene)methyl]-2,4-dimethylpyrrole-3-carboxylic Acid(Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrol-3-carboxylic acid
MFCD11521323C16H13FN2O35-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic AcidCHEMBL1778707Des-N-(2-Diethylaminoethyl)amide Sunitinib Acid5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acidSunitinib Impurity 34
Datenbank-Bezeichner
- CAS
356068-93-4- PubChem CID
- 10979489
- ChEMBL
CHEMBL1778707- UNII
- 3TA57TDQ6K
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,1
- Polarare Oberfläche (TPSA)
- 82,2 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 2
- Schwere Atome
- 22
- Formalladung
- 0
- Komplexität
- 522
Physikochemische Eigenschaften
- Schmelzpunkt
- 320 °C · 320 °C (decomp)
- Siedepunkt
- 588.4 · 588.4±50.0 °C(Predicted)
- Dichte
- 1.454 · 1.454±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- Löslichkeit
- Aqueous Base (Slightly, Heated), DMSO (Slightly, Heated)
- Aggregatzustand
- Solid
- pka
- 5.79 · 5.79±0.50(Predicted)
- Farbe
- Dark Orange
- InChI
- InChI=1S/C16H13FN2O3/c1-7-13(18-8(2)14(7)16(21)22)6-11-10-5-9(17)3-4-12(10)19-15(11)20/h3-6,18H,1-2H3,(H,19,20)(H,21,22)/b11-6-
- InChIKey
- RBHBOUYXUXWCNJ-WDZFZDKYSA-N
- SMILES
- N1C(/C=C2/C3=C(NC/2=O)C=CC(F)=C3)=C(C)C(C(O)=O)=C1C
Chemie und Industrie
Anwendungen
VerwendenDes-N-(2-Diethylaminoethyl)amide Sunitinib Acid is an impurity of Sunitinib (S819995), a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). Antineoplastic.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter50 Anbieter
上海宇之诚医药科技有限公司13361818591 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
Shanghai Yingrui Biopharma Co.,Ltd21-33585366 · [email protected]
上海皓竹医药科技有限公司18912729622 · [email protected]
陕西缔都化学有限公司029-029-81123119 17391733320 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
韶远科技(上海)有限公司021-50795510 4000665055 · [email protected]
芷威(上海)化学科技有限公司021-20221225 13917446399 · [email protected]
宁波亿诺化学品有限公司86-574-27787657 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
常州科化生物科技有限公司0519-68985668 13685222090 · [email protected]
安庆奇创药业有限公司18061456370
广州市亿邦医药科技有限公司+86 (20) 28996708,29078958,28139708,29076128,28133708,28139728,28139738,28133718,021-31663278,021-31663578,021-60538387
南京圣亿来化工有限公司19951936396 · [email protected]
希瓦生物科技(广州)有限公司13268215580 · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
上海景颜化工科技有限公司13817811078 · [email protected]
上海尺水药物研究有限公司[email protected] 13564957716 · [email protected]
医恩医疗系统研发(上海)有限公司021-58958002 18930822973 · [email protected]
武汉丰泰威远科技有限公司+86-27-8746-5837 +86-18627785180 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
成都格蓝洋生物医药科技有限公司86+28-85337952 18081025021 · [email protected]
无锡捷化医药科技有限公司0510-83588313-811 18800520310 · [email protected]
潍坊鼎弘医药科技有限公司18663683121 · [email protected]
南京精瑞久安生物技术有限公司025-58196018 800028039 · [email protected]
南京诺利斯医药科技有限公司13901585132 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
HBCChem, Inc.+1-510-219-6317 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
南京弗思特医药科技有限公司025-83172655 13585105703 · [email protected]
上海御略医药科技有限公司021-60345187 13671753212 · [email protected]
杭州杰恒化工有限公司0571-87396432 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
上海嵩爰化工科技有限公司010-1234567 18521000990 · [email protected]
上海孚一生物科技有限公司+86 (21) 61124340
上海皓骏医药科技有限公司021-34621078 13120882795 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
江苏倍达医药科技有限公司0512-63009836 18994340901 · [email protected]
武汉峰耀同辉化学制品有限公司027-87466205 15377579727 · [email protected]
厦门志信化学有限公司+86-5922680277 +86-13806087780 · [email protected]
艾吉析科技(上海)有限公司17721401538;17717235263 17721401538 · [email protected]
sgtlifesciences pvt ltd+91-8790379245 · [email protected]
武汉市罗氏科技发展有限公司19171595131 · [email protected]
嘉兴市浙嘉生物科技有限公司0573-85609002 · [email protected]
湖北新烯王生物有限公司0715-8108888-8009 · [email protected]
成都叮当时代医药科技有限公司028-86040038 · [email protected]
南京艾比克斯生化科技有限公司025-87193546 18652950785 · [email protected]
上海前衍生物科技有限公司02781293128 · [email protected]
Zugehörige Reaktionen
39
Verknüpfte Notizen
Wird geladen…